インフルエンザ診断市場規模、シェア、成長分析、製品別、検査別、エンドユーザー別、地域別 - 業界予測、2024～2031年

インフルエンザ診断の世界市場規模は、2022年に13億米ドルと評価され、2023年の14億米ドルから2031年には21億米ドルに成長し、予測期間中（2024-2031年）のCAGRは4.9%で成長する見通しです。

ヘルスケア支出の増加と効果的な治療の進歩が、世界の年齢中央値の上昇に寄与しています。WHO、CDC、欧州疾病予防管理センター（European Centre for Disease Prevention and Control）などの規制機関は、健康課題に体系的に対処するため、罹患率と有病率のデータを熱心に追跡しています。 Global Influenza Program（GIP）のような共同イニシアチブは、インフルエンザおよび関連するパンデミックを管理するための技術的支援と戦略的指針を強化することを目的としています。こうした努力にもかかわらず、COVID-19パンデミックは、製造施設の一時閉鎖やサプライチェーンの混乱につながり、インフルエンザ診断市場に大きな影響を与えました。さらに、COVID-19とインフルエンザの症状が類似していることから、同時検査が必要となり、このような課題の中でインフルエンザ診断の需要を促進し、最終的に予測期間中のこの市場分野の成長を促進しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ
• 特許分析

インフルエンザ診断市場規模：製品別およびCAGR（2024～2031年）

• 市場概要
• 検査キットと試薬
• 機器
• その他

インフルエンザ診断市場規模：検査別およびCAGR（2024～2031年）

• 市場概要
• 分子診断検査
  • ポリメラーゼ連鎖反応
  • 等温核酸増幅検査
  • 検査
• 転写増幅法ベース検査
• ループ媒介等温増幅法ベース検査
• 核酸配列ベース増幅検査
• 従来型診断検査
• 迅速インフルエンザ診断検査
• ウイルス培養検査
• 直接蛍光抗体検査
• 血清学的検査

インフルエンザ診断市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 診断検査室
• 病院と診療所
• その他

インフルエンザ診断市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Thermo Fisher Scientific（US）
• Becton, Dickinson and Company（US）
• F. Hoffmann-La Roche AG（Switzerland）
• Hologic, Inc.（US）
• Abbott Laboratories, Inc.（US）
• DiaSorin（Italy）
• QIAGEN N.V.（Netherlands）
• Fujirebio Diagnostics, Inc.（Japan）
• Meridian Bioscience, Inc.（US）
• Luminex Corporation（US）
• Seegene Inc.（South Korea）
• Bio-Rad Laboratories, Inc.（US）
• Alere Inc.（US）
• GenMark Diagnostics, Inc.（US）
• Roche Diagnostics（Switzerland）
• BioMerieux SA（France）
• Cepheid（US）
• SD Biosensor（South Korea）
• Acon Laboratories, Inc.（US）
• Inverness Medical Innovations, Inc.（US）

結論と推奨事項

Global Influenza Diagnostics Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.4 billion in 2023 to USD 2.1 billion by 2031, growing at a CAGR of 4.9% during the forecast period (2024-2031).

Rising healthcare expenditures and effective treatment advancements are contributing to a global increase in median age. Regulatory organizations such as WHO, CDC, and the European Centre for Disease Prevention and Control are diligently tracking incidence and prevalence data to systematically address health challenges. Collaborative initiatives like the Global Influenza Program (GIP) aim to enhance technical support and strategic guidance in managing influenza and related pandemics. Despite these efforts, the COVID-19 pandemic has significantly impacted the influenza diagnostics market, leading to temporary closures of manufacturing facilities and disruptions in supply chains. Furthermore, the similarities between COVID-19 and influenza symptoms necessitate concurrent testing, driving the demand for influenza diagnostics amidst these challenges, ultimately fostering growth in this market sector during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Influenza Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Influenza Diagnostics Market Segmental Analysis

Global Influenza Diagnostics Market is segmented by Product, Test, End User and Region. Based on Product, the market is segmented into Test kit and Reagents, Instruments, Other Products. Based on Test, the market is segmented into Molecular Diagnostic Test (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification, Tests), Transcription Mediated Amplification Based Assay, Loop Mediated Isothermal Amplification Based Assay, Nucleic Acid Sequence based Amplification Tests, Traditional Diagnostics Tests (Rapid Influenza Diagnostic Test, Viral Culture Test, Direct Fluorescent Antibody Test, Serological Tests). Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals and Clinics, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Influenza Diagnostics Market

A key driver in the global Influenza Diagnostics market is the increased emphasis on research and development in this area. The escalating global incidence of influenza has intensified efforts to create accurate and rapid diagnostic methods for identifying influenza viruses. This focus on enhancing diagnostic capabilities is expected to significantly propel market growth. Furthermore, government initiatives aimed at combating influenza outbreaks, along with advancements in technology, are enhancing diagnostic efficacy. Additionally, the growing prevalence of related health issues, such as cardiovascular diseases and diabetes, will also contribute to the upward momentum of the Influenza Diagnostics market.

Restraints in the Global Influenza Diagnostics Market

The Global Influenza Diagnostics market faces several restraints, particularly the shortage of skilled technicians, which significantly hampers its growth potential. The scarcity of qualified professionals, compounded by an unstable regulatory environment regarding the approval of new diagnostic tests, poses a considerable challenge. Additionally, developing economies often struggle with inadequate healthcare infrastructure, further complicating the situation. As a result, these factors collectively hinder the market's expansion, making it more difficult to implement and utilize advanced diagnostic technologies effectively in the fight against influenza. Addressing these issues is crucial for fostering growth and improving diagnostic capabilities worldwide.

Market Trends of the Global Influenza Diagnostics Market

The global influenza diagnostics market is poised for substantial growth, driven by a notable rise in reported influenza cases worldwide. With the Centers for Disease Control and Prevention (CDC) estimating annual influenza-related fatalities in the U.S. between 12,000 and 79,000, the urgency for effective diagnostic solutions becomes ever more critical. Furthermore, heightened awareness surrounding the significance of early detection and proactive disease management is propelling demand for advanced testing technologies. As healthcare providers and patients prioritize timely intervention to mitigate influenza outbreaks, the market is expected to expand significantly during the forecast period, reflecting both public health imperatives and technological advancements in diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Influenza Diagnostics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Test kit and Reagents
• Instruments
• Others

Influenza Diagnostics Market Size by Test & CAGR (2024-2031)

• Market Overview
• Molecular Diagnostic Test
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification
  • Tests
• Transcription Mediated Amplification Based Assay
• Loop Mediated Isothermal Amplification Based Assay
• Nucleic Acid Sequence based Amplification Tests
• Traditional Diagnostics Tests
• Rapid Influenza Diagnostic Test
• Viral Culture Test
• Direct Fluorescent Antibody Test
• Serological Test

Influenza Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Diagnostic Laboratories
• Hospitals and Clinics
• Others

Influenza Diagnostics Market Size & CAGR (2024-2031)

• North America, (Product, Test, End User)
  • US
  • Canada
• Europe, (Product, Test, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Test, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Test, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Diagnostics, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inverness Medical Innovations, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation